Celebrating Bringing Science
to Life

Since the early 1980's, Genentech has spent more than 25 years on the research and development of Herceptin® (Trastuzumab), a revolutionary medicine that has been used to treat more than 420,000 women with breast cancer. This year marks the 10-year anniversary of Herceptin's initial FDA approval.

Genentech Named Top Employer by Science Magazine

On October 10, 2008, Genentech was named "top employer in the biopharmaceutical industry" by Science magazine. This is the sixth number one ranking for the company.